Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3156–3162. doi: 10.1128/jcm.35.12.3156-3162.1997

Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis.

D J Marshall 1, L M Heisler 1, V Lyamichev 1, C Murvine 1, D M Olive 1, G D Ehrlich 1, B P Neri 1, M de Arruda 1
PMCID: PMC230140  PMID: 9399512

Abstract

We describe the application of a new DNA-scanning method, which has been termed Cleavase Fragment Length Polymorphism (CFLP; Third Wave Technologies, Inc., Madison, Wis.), for the determination of the genotype of hepatitis C virus (HCV). CFLP analysis results in the generation of structural fingerprints that allow discrimination of different DNA sequences. We analyzed 251-bp cDNA products generated by reverse transcription-PCR of the well-conserved 5'-noncoding region of HCV. We determined the genotypes of 87 samples by DNA sequencing and found isolates representing 98% of the types typically encountered in the United States, i.e., types 1a, 1b, 2a/c, 2b, 3a, and 4. Blinded CFLP analysis of these samples was 100% concordant with DNA sequencing results, such that closely related genotypes yielded patterns with strong familial resemblance whereas more divergent sequences yielded patterns with pronounced dissimilarities. In each case, the aggregate pattern was indicative of genotypic grouping, while finer changes suggested subgenotypic differences. We also assessed the reproducibility of CFLP analysis in HCV genotyping by analyzing three distinct isolates belonging to a single subtype. These three isolates yielded indistinguishable CFLP patterns, as did replicate analysis of a single isolate. This study demonstrates the suitability of this technology for HCV genotyping and suggests that it may provide a low-cost, high-throughput alternative to DNA sequencing or other, more costly or cumbersome genotyping approaches.

Full Text

The Full Text of this article is available as a PDF (372.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altamirano M., Delaney A., Wong A., Marostenmaki J., Pi D. Identification of hepatitis C virus genotypes among hospitalized patients in British Columbia, Canada. J Infect Dis. 1995 Apr;171(4):1034–1038. doi: 10.1093/infdis/171.4.1034. [DOI] [PubMed] [Google Scholar]
  2. Brow M. A., Oldenburg M. C., Lyamichev V., Heisler L. M., Lyamicheva N., Hall J. G., Eagan N. J., Olive D. M., Smith L. M., Fors L. Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage. J Clin Microbiol. 1996 Dec;34(12):3129–3137. doi: 10.1128/jcm.34.12.3129-3137.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bukh J., Miller R. H., Purcell R. H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995 Feb;15(1):41–63. doi: 10.1055/s-2007-1007262. [DOI] [PubMed] [Google Scholar]
  4. Cha T. A., Beall E., Irvine B., Kolberg J., Chien D., Kuo G., Urdea M. S. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7144–7148. doi: 10.1073/pnas.89.15.7144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen Y., Cooper D. L., Ehrlich G. D. Comparative analysis of three nucleic acid-based detection systems for hepatitis C virus RNA in plasma from liver transplant recipients. Mol Cell Probes. 1996 Oct;10(5):331–336. doi: 10.1006/mcpr.1996.0045. [DOI] [PubMed] [Google Scholar]
  6. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  7. Colucci G., Gutekunst K. Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C. J Viral Hepat. 1997;4 (Suppl 1):75–78. doi: 10.1111/j.1365-2893.1997.tb00164.x. [DOI] [PubMed] [Google Scholar]
  8. Constantine N. T., Abdel-Hamid M., Oldach D. Rapid genotyping of hepatitis C virus. N Engl J Med. 1995 Sep 21;333(12):800–800. doi: 10.1056/nejm199509213331213. [DOI] [PubMed] [Google Scholar]
  9. Davidson F., Simmonds P., Ferguson J. C., Jarvis L. M., Dow B. C., Follett E. A., Seed C. R., Krusius T., Lin C., Medgyesi G. A. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol. 1995 May;76(Pt 5):1197–1204. doi: 10.1099/0022-1317-76-5-1197. [DOI] [PubMed] [Google Scholar]
  10. Detmer J., Lagier R., Flynn J., Zayati C., Kolberg J., Collins M., Urdea M., Sánchez-Pescador R. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol. 1996 Apr;34(4):901–907. doi: 10.1128/jcm.34.4.901-907.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
  12. Dusheiko G., Schmilovitz-Weiss H., Brown D., McOmish F., Yap P. L., Sherlock S., McIntyre N., Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994 Jan;19(1):13–18. [PubMed] [Google Scholar]
  13. Lau J. Y., Davis G. L., Prescott L. E., Maertens G., Lindsay K. L., Qian K., Mizokami M., Simmonds P. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med. 1996 May 15;124(10):868–876. doi: 10.7326/0003-4819-124-10-199605150-00002. [DOI] [PubMed] [Google Scholar]
  14. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A., Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993 Jan;33(1):7–13. doi: 10.1046/j.1537-2995.1993.33193142314.x. [DOI] [PubMed] [Google Scholar]
  15. Nousbaum J. B., Pol S., Nalpas B., Landais P., Berthelot P., Bréchot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med. 1995 Feb 1;122(3):161–168. doi: 10.7326/0003-4819-122-3-199502010-00001. [DOI] [PubMed] [Google Scholar]
  16. Olynyk J. K., Bacon B. R. Hepatitis C. Recent advances in understanding and management. Postgrad Med. 1995 Jul;98(1):79-81, 86-7, 91-4. [PubMed] [Google Scholar]
  17. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  18. Rossetti S., Englisch S., Bresin E., Pignatti P. F., Turco A. E. Detection of mutations in human genes by a new rapid method: cleavage fragment length polymorphism analysis (CFLPA). Mol Cell Probes. 1997 Apr;11(2):155–160. doi: 10.1006/mcpr.1996.0085. [DOI] [PubMed] [Google Scholar]
  19. Sharara A. I., Hunt C. M., Hamilton J. D. Hepatitis C. Ann Intern Med. 1996 Oct 15;125(8):658–668. doi: 10.7326/0003-4819-125-8-199610150-00006. [DOI] [PubMed] [Google Scholar]
  20. Simmonds P., McOmish F., Yap P. L., Chan S. W., Lin C. K., Dusheiko G., Saeed A. A., Holmes E. C. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 1993 Apr;74(Pt 4):661–668. doi: 10.1099/0022-1317-74-4-661. [DOI] [PubMed] [Google Scholar]
  21. Stuyver L., Rossau R., Wyseur A., Duhamel M., Vanderborght B., Van Heuverswyn H., Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993 Jun;74(Pt 6):1093–1102. doi: 10.1099/0022-1317-74-6-1093. [DOI] [PubMed] [Google Scholar]
  22. Stuyver L., Wyseur A., van Arnhem W., Hernandez F., Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol. 1996 Sep;34(9):2259–2266. doi: 10.1128/jcm.34.9.2259-2266.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Lesmana L. A., Miyakawa Y., Mayumi M. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol. 1996 Feb;77(Pt 2):293–301. doi: 10.1099/0022-1317-77-2-293. [DOI] [PubMed] [Google Scholar]
  24. Tokita H., Okamoto H., Tsuda F., Song P., Nakata S., Chosa T., Iizuka H., Mishiro S., Miyakawa Y., Mayumi M. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11022–11026. doi: 10.1073/pnas.91.23.11022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tsubota A., Chayama K., Ikeda K., Yasuji A., Koida I., Saitoh S., Hashimoto M., Iwasaki S., Kobayashi M., Hiromitsu K. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology. 1994 May;19(5):1088–1094. [PubMed] [Google Scholar]
  26. Young K. K., Resnick R. M., Myers T. W. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 1993 Apr;31(4):882–886. doi: 10.1128/jcm.31.4.882-886.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zein N. N., Persing D. H. Hepatitis C genotypes: current trends and future implications. Mayo Clin Proc. 1996 May;71(5):458–462. doi: 10.4065/71.5.458. [DOI] [PubMed] [Google Scholar]
  28. Zein N. N., Rakela J., Krawitt E. L., Reddy K. R., Tominaga T., Persing D. H. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med. 1996 Oct 15;125(8):634–639. doi: 10.7326/0003-4819-125-8-199610150-00002. [DOI] [PubMed] [Google Scholar]
  29. Zeuzem S., Franke A., Lee J. H., Herrmann G., Ruster B., Roth W. K. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology. 1996 Nov;24(5):1003–1009. doi: 10.1002/hep.510240505. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES